We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 354

Biopharmaceuticals to collaborate on cancer drug discovery

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

FORMA Therapeutics Holdings, LLC has reportedly entered a strategic collaboration agreement with Celgene Corp. to discover, develop and commercialize

House passes FDA funding bill

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

The U.S. House of Representatives approved legislation (H.R. 5651) on May 30, 2012, that, among other things, would revise and extend the user fees that industry pays the Food and Drug Administration (FDA) to expedite safety reviews of new medicines and medical devices

DOJ seeks earliest calendaring before Federal Circuit in Myriad Genetics

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 24 2011

Acting Solicitor General Neal Katyal has requested an April 4, 2011, oral argument date in a case before the Federal Circuit Court of Appeals asking whether and to what extent genetic discoveries may be patented

IOM publishes report on the effects of falsified and substandard medicines

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • February 21 2013

At the request of the U.S. Food and Drug Administration (FDA), national think tank the Institute of Medicine (IOM) has published a report that

Cincinnati investor closes $4.4 million fund to invest in startups

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 30 2011

Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio

IOM deems 510(k) medical-device clearance process flawed; FDA seeks comments

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 4 2011

The Institute of Medicine (IOM) has issued a report titled “Medical Devices and the Public’s Health, The FDA 510(k) Clearance Process at 35 Years,” calling for an overhaul of Food and Drug Administration (FDA) procedures for approving medical devices that are considered a moderate risk to patients and are substantially equivalent to any previously cleared device or one that was on the market before the Medical Device Amendments were enacted in 1976

Biotech set to raise $86 million in IPO to support cancer and IEM products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

Agios Pharmaceuticals, Inc. has filed a registration statement with the U.S. Securities and Exchange Commission indicating its intent to raise up to

Biotech receives $32.5 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Celator Pharmaceuticals, Inc., a Princeton, New Jersey-based company that develops cancer therapies, has raised $32.5 million in the final closing of

Fewer small biotech companies go public

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 10 2011

Smaller biotechnology companies maneuvering through drug-development regulations are reportedly focusing their efforts on licensing products in development or selling their businesses to large pharmaceutical companies rather than pursuing an initial public offering (IPO

University of Massachusetts, UK collaborate on stem cell project

  • Shook Hardy & Bacon LLP
  • -
  • United Kingdom, USA
  • -
  • March 24 2011

The University of Massachusetts Human Stem Cell Bank and Registry and the United Kingdom Stem Cell Bank have reportedly agreed to collaborate on best practices for stem cell banking, including delivery of stem cell lines for clinical use, and may explore funding opportunities for joint research projects